Annual Total Debt
$537.00 K
-$19.41 M-97.31%
December 31, 2023
Summary
- As of February 8, 2025, AVTX annual total debt is $537.00 thousand, with the most recent change of -$19.41 million (-97.31%) on December 31, 2023.
- During the last 3 years, AVTX annual total debt has risen by +$111.00 thousand (+26.06%).
- AVTX annual total debt is now -98.39% below its all-time high of $33.32 million, reached on December 31, 2021.
Performance
AVTX Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Debt
$550.00 K
+$2000.00+0.36%
September 30, 2024
Summary
- As of February 8, 2025, AVTX quarterly total debt is $550.00 thousand, with the most recent change of +$2000.00 (+0.36%) on September 30, 2024.
- Over the past year, AVTX quarterly total debt has increased by +$2000.00 (+0.36%).
- AVTX quarterly total debt is now -98.37% below its all-time high of $33.70 million, reached on March 31, 2022.
Performance
AVTX Quarterly Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Debt Formula
Total Debt = Short Term Debt + Long Term Debt
AVTX Total Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -97.3% | +0.4% |
| 3 y3 years | +26.1% | -97.2% |
| 5 y5 years | +100.0% | -96.7% |
AVTX Total Debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -98.4% | at low | -98.4% | +2.6% |
| 5 y | 5-year | -98.4% | +244.7% | -98.4% | -100.0% |
| alltime | all time | -98.4% | -100.0% | -98.4% | -100.0% |
Avalo Therapeutics Total Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $550.00 K(+0.4%) |
| Jun 2024 | - | $548.00 K(+0.6%) |
| Mar 2024 | - | $545.00 K(+1.5%) |
| Dec 2023 | $537.00 K(-97.3%) | $537.00 K(+0.2%) |
| Sep 2023 | - | $536.00 K(-96.3%) |
| Jun 2023 | - | $14.65 M(-27.8%) |
| Mar 2023 | - | $20.30 M(+1.8%) |
| Dec 2022 | $19.95 M(-40.1%) | $19.95 M(+1.8%) |
| Sep 2022 | - | $19.59 M(+1.8%) |
| Jun 2022 | - | $19.24 M(-42.9%) |
| Mar 2022 | - | $33.70 M(+1.2%) |
| Dec 2021 | $33.32 M(+7721.1%) | $33.32 M(+1.9%) |
| Sep 2021 | - | $32.70 M(+87.6%) |
| Jun 2021 | - | $17.43 M(+4782.6%) |
| Mar 2021 | - | $357.00 K(-16.2%) |
| Dec 2020 | $426.00 K(+173.4%) | $426.00 K(-5.1%) |
| Sep 2020 | - | $448.70 K(+4.0%) |
| Jun 2020 | - | $431.50 K(>+9900.0%) |
| Mar 2020 | - | $0.00(-100.0%) |
| Dec 2019 | $155.80 K | $155.80 K(-99.1%) |
| Sep 2019 | - | $16.43 M(-0.7%) |
| Jun 2019 | - | $16.54 M(+7.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | $15.35 M(>+9900.0%) |
| Dec 2018 | $0.00(0.0%) | $0.00(-100.0%) |
| Sep 2018 | - | $15.40 M(-0.2%) |
| Jun 2018 | - | $15.43 M(+0.3%) |
| Mar 2018 | - | $15.38 M(>+9900.0%) |
| Dec 2017 | $0.00(-100.0%) | $0.00(0.0%) |
| Sep 2017 | - | $0.00(-100.0%) |
| Jun 2017 | - | $607.60 K(-59.3%) |
| Mar 2017 | - | $1.49 M(-36.6%) |
| Dec 2016 | $2.35 M(-57.7%) | $2.35 M(-26.2%) |
| Sep 2016 | - | $3.19 M(-20.3%) |
| Jun 2016 | - | $4.00 M(-16.5%) |
| Mar 2016 | - | $4.79 M(-13.8%) |
| Dec 2015 | $5.56 M(-22.9%) | $5.56 M(-12.1%) |
| Sep 2015 | - | $6.32 M(-10.3%) |
| Jun 2015 | - | $7.05 M(-2.9%) |
| Mar 2015 | - | $7.26 M(+0.6%) |
| Dec 2014 | $7.21 M(>+9900.0%) | $7.21 M(>+9900.0%) |
| Sep 2014 | - | $0.00(0.0%) |
| Jun 2014 | - | $0.00(0.0%) |
| Mar 2014 | - | $0.00 |
| Dec 2013 | $0.00 | - |
FAQ
- What is Avalo Therapeutics annual total debt?
- What is the all time high annual total debt for Avalo Therapeutics?
- What is Avalo Therapeutics annual total debt year-on-year change?
- What is Avalo Therapeutics quarterly total debt?
- What is the all time high quarterly total debt for Avalo Therapeutics?
- What is Avalo Therapeutics quarterly total debt year-on-year change?
What is Avalo Therapeutics annual total debt?
The current annual total debt of AVTX is $537.00 K
What is the all time high annual total debt for Avalo Therapeutics?
Avalo Therapeutics all-time high annual total debt is $33.32 M
What is Avalo Therapeutics annual total debt year-on-year change?
Over the past year, AVTX annual total debt has changed by -$19.41 M (-97.31%)
What is Avalo Therapeutics quarterly total debt?
The current quarterly total debt of AVTX is $550.00 K
What is the all time high quarterly total debt for Avalo Therapeutics?
Avalo Therapeutics all-time high quarterly total debt is $33.70 M
What is Avalo Therapeutics quarterly total debt year-on-year change?
Over the past year, AVTX quarterly total debt has changed by +$2000.00 (+0.36%)